Work

Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor

Year: 2019

Type: review

Source: Seminars in Immunology

DOI: 10.1016/j.smim.2019.101305

Authors: Elisa Ruffo, Richard C. Wu, Tullia C. Bruno, Creg J. Workman, Dario A.A. Vignali

Institutions: University of Pittsburgh, UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Associazione Italiana per la Ricerca sul Cancro, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: Training in Cancer Therapeutics Research, Interleukin-35 and the tumor microenvironment, Head and Neck Cancer SPORE, Cancer Center Support Grant, Synergies among inhibitory receptors in tolerance and disease, Structure, Function and Mechanistic Analysis of LAG3

OpenAlex ID: W2979790494

FWCI: 3.194

Cites: 77

Cited by: 382

Related to: 10